STOCK TITAN
  1. Home
  2. Sec-filings
  3. BMY
  4. [Form 4] BRISTOL MYERS SQUIBB CO Insider Trading Activity

BMY Form 4: EVP Adam Lenkowsky reports 22,568 RSUs grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Bristol Myers Squibb (BMY) reported an insider equity award. EVP and Chief Commercial Officer Adam Lenkowsky filed a Form 4 showing an award of 22,568 restricted stock units on November 3, 2025. Each RSU converts into one share of common stock upon vesting, which occurs in three equal annual installments beginning November 3, 2026.

Following the reported transactions, Lenkowsky’s beneficial ownership includes 12,439 shares held directly, 5,772.35 shares through the BMS Savings and Investment Program (based on a recent 401(k) statement), and 5,723.157 shares held by spouse.

Positive

  • None.

Negative

  • None.
Insider Lenkowsky Adam
Role EVP, Chief Commercial Officer
Type Security Shares Price Value
Grant/Award Restricted Stock Units 22,568 $0.00 --
holding Common Stock, $0.10 par value -- -- --
holding Common Stock, $0.10 par value -- -- --
holding Common Stock, $0.10 par value -- -- --
Holdings After Transaction: Restricted Stock Units — 22,568 shares (Direct); Common Stock, $0.10 par value — 12,439 shares (Direct); Common Stock, $0.10 par value — 5,772.35 shares (Indirect, BMS Savings and Investment Program)
Footnotes (1)
  1. Based on recent 401(k) plan statement. Each restricted stock unit converts into one share of common stock upon vesting. The restricted stock units vest in three equal annual installments beginning on November 3, 2026.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lenkowsky Adam
(Last) (First) (Middle)
BRISTOL-MYERS SQUIBB COMPANY
ROUTE 206 AND PROVINCE LINE ROAD
(Street)
PRINCETON NJ 08543
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
BRISTOL MYERS SQUIBB CO [ BMY ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, Chief Commercial Officer
3. Date of Earliest Transaction (Month/Day/Year)
11/03/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $0.10 par value 12,439 D
Common Stock, $0.10 par value 5,772.35(1) I BMS Savings and Investment Program
Common Stock, $0.10 par value 5,723.157 I By Spouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (2) 11/03/2025 A 22,568 (3) 11/03/2028 Common Stock, $0.10 par value 22,568 $0 22,568 D
Explanation of Responses:
1. Based on recent 401(k) plan statement.
2. Each restricted stock unit converts into one share of common stock upon vesting.
3. The restricted stock units vest in three equal annual installments beginning on November 3, 2026.
Remarks:
/s/ Lisa A. Atkins, attorney-in-fact for Adam Lenkowsky 11/04/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did BMY disclose in this Form 4?

An award of 22,568 restricted stock units to EVP and Chief Commercial Officer Adam Lenkowsky on November 3, 2025.

How do the RSUs reported by BMY vest?

They vest in three equal annual installments beginning on November 3, 2026.

What is the RSU-to-share conversion for BMY's grant?

Each RSU converts into one share of Bristol Myers Squibb common stock upon vesting.

What are Adam Lenkowsky’s direct BMY share holdings after this filing?

He holds 12,439 shares directly.

What indirect BMY holdings are reported for Adam Lenkowsky?

He reports 5,772.35 shares via the BMS Savings and Investment Program and 5,723.157 shares by spouse.

What is Adam Lenkowsky’s role at BMY?

He is EVP, Chief Commercial Officer.